We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAGN
2976
Magnera Corp
MAGN
$430M
$24K ﹤0.01%
655
-134
-17% -$5.47K
LEV
2977
DELISTED
The Lion Electric Company
LEV
$24K ﹤0.01%
10,631
+9,822
+1,214% +$26.6K
TELL
2978
DELISTED
Tellurian Inc.
TELL
$24K ﹤0.01%
14,173
-40,511
-74% -$101K
VBIV
2979
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$24K ﹤0.01%
2,008
+1,602
+395% +$28.3K
ESMT
2980
DELISTED
EngageSmart, Inc.
ESMT
$24K ﹤0.01%
1,380
-1,990
-59% -$36.5K
TRTN
2981
DELISTED
Triton International Limited
TRTN
$24K ﹤0.01%
353
-3,581
-91% -$227K
STCN
2982
DELISTED
Steel Connect, Inc. Common Stock
STCN
$24K ﹤0.01%
1,812
+1,398
+338% +$17.3K
FSTX
2983
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$24K ﹤0.01%
3,724
-28,574
-88% -$158K
APG icon
2984
APi Group
APG
$18.8B
$23K ﹤0.01%
1,851
-28,758
-94% -$332K
ATI icon
2985
ATI
ATI
$30.9B
$23K ﹤0.01%
755
-23,955
-97% -$701K
BMEA icon
2986
Biomea Fusion
BMEA
$94.2M
$23K ﹤0.01%
2,784
-5,598
-67% -$47.8K
BYRN icon
2987
Byrna Technologies
BYRN
$95.5M
$23K ﹤0.01%
+2,914
New +$21.8K
CATO icon
2988
Cato Corp
CATO
$67.7M
$23K ﹤0.01%
2,436
-395
-14% -$4.04K
CEVA icon
2989
CEVA Inc
CEVA
$882M
$23K ﹤0.01%
895
-2,674
-75% -$72K
DIT icon
2990
AMCON Distributing
DIT
$66.4M
$23K ﹤0.01%
+194
New +$24K
GAIN icon
2991
Gladstone Investment Corp
GAIN
$655M
$23K ﹤0.01%
1,814
-1,232
-40% -$16.2K
GANX icon
2992
Gain Therapeutics
GANX
$90M
$23K ﹤0.01%
7,152
+1,891
+36% +$5.91K
GH icon
2993
Guardant Health
GH
$21.2B
$23K ﹤0.01%
862
-1,236
-59% -$56.6K
GRNT icon
2994
Granite Ridge Resources
GRNT
$683M
$23K ﹤0.01%
+2,481
New +$22.4K
HOOK
2995
DELISTED
HOOKIPA Pharma
HOOK
$23K ﹤0.01%
2,856
+2,854
+142,700% +$30.9K
STRR
2996
Star Equity Holdings
STRR
$39.4M
$23K ﹤0.01%
999
+339
+51% +$9.66K
KROS icon
2997
Keros Therapeutics
KROS
$204M
$23K ﹤0.01%
486
-2,357
-83% -$110K
MATX icon
2998
Matsons
MATX
$6.53B
$23K ﹤0.01%
362
-2,680
-88% -$177K
MGNX icon
2999
MacroGenics
MGNX
$249M
$23K ﹤0.01%
3,425
-650
-16% -$3.56K
NPK icon
3000
National Presto Industries
NPK
$1B
$23K ﹤0.01%
343
+212
+162% +$14.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.